SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-22-019277
Filing Date
2022-05-10
Accepted
2022-05-10 16:11:47
Documents
47
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q evok-10q_20220331.htm   iXBRL 10-Q 945473
2 EX-10..1 evok-ex101_427.htm EX-10..1 21540
3 EX-31.1 evok-ex311_7.htm EX-31.1 9588
4 EX-31.2 evok-ex312_6.htm EX-31.2 9861
5 EX-32.1 evok-ex321_8.htm EX-32.1 6542
6 EX-32.2 evok-ex322_9.htm EX-32.2 6713
7 GRAPHIC gz0mxiaiyk4p000001.jpg GRAPHIC 56050
  Complete submission text file 0001564590-22-019277.txt   3441630

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA evok-20220331.xsd EX-101.SCH 33154
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE evok-20220331_cal.xml EX-101.CAL 22988
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE evok-20220331_def.xml EX-101.DEF 92956
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE evok-20220331_lab.xml EX-101.LAB 237091
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE evok-20220331_pre.xml EX-101.PRE 173981
41 EXTRACTED XBRL INSTANCE DOCUMENT evok-10q_20220331_htm.xml XML 361570
Mailing Address 420 STEVENS AVENUE SUITE 370 SOLANA BEACH CA 92075
Business Address 420 STEVENS AVENUE SUITE 370 SOLANA BEACH CA 92075 858-345-1494
Evoke Pharma Inc (Filer) CIK: 0001403708 (see all company filings)

IRS No.: 208447886 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36075 | Film No.: 22909723
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences